EUDA HEALTH HOLDINGS LTD
EUDA · NASDAQ
Updated at 2026-10-15 10:35:18
- Today's High
- $16.25
- Today’s Low
- $14.95
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $16.25
- Previous Close
- $15.39
- Volume
- 9.02K
- Market Cap
- $46.11M
- P/E Ratio
- --
- EPS
- $-2.13
Previous Day Range
52-Week Range
Company Overview
- Sector
- REAL ESTATE
- Industry
- Health Care
- Sub-industry
- REAL ESTATE SERVICES
- Headquarters
- 60 KAKI BUKIT PLACE, SINGAPORE, SINGAPORE, 415979
- Country
- SG
- Listing Date
- 2021-07-28
- Fiscal Year End
- December
- Shares Outstanding
- 2.49M
- CIK
- 0001847846
- Website
- euda.com/press-release
EUDA Health Holdings Limited is a forward-looking biopharmaceutical company focused on innovating treatments for rare diseases and addressing unmet medical needs. Leveraging advanced technologies, the firm is developing a robust clinical pipeline with a particular emphasis on supportive care and immune modulation. EUDA's strong commitment to research and development positions it favorably in the healthcare landscape, aiming to enhance patient outcomes and expand access to crucial therapies.
Financial Metrics
Revenue
2026-03-31
$6.82M
2025-09-30
$1.88M
2025-03-31
$1.52M
2024-09-30
$1.05M
Operating Expenses
2026-03-31
$5.47M
2025-09-30
$1.75M
2025-03-31
$983.74K
2024-09-30
$655.09K
Net Income
2026-03-31
-$2.77M
2025-09-30
-$784.38K
2025-03-31
-$602K
2024-09-30
$735.33K
Net Profit Margin
2026-03-31
-40.65%
2025-09-30
-41.68%
2025-03-31
-39.38%
2024-09-30
69.93%
Earnings Per Share
2026-03-31
--
2025-09-30
$-0.03
2025-03-31
$-0.02
2024-09-30
$-0.59
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-03-31
-$2.09M
2025-09-30
-$540.15K
2025-03-31
-$476.86K
2024-09-30
-$476.93K
Effective Tax Rate
2026-03-31
-1.53%
2025-09-30
-3.04%
2025-03-31
-0.35%
2024-09-30
-0.38%
| Item | 2026-03-31 | 2025-09-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | $6.82M | $1.88M | $1.52M | $1.05M |
| Operating Expenses | $5.47M | $1.75M | $983.74K | $655.09K |
| Net Income | -$2.77M | -$784.38K | -$602K | $735.33K |
| Net Profit Margin | -40.65% | -41.68% | -39.38% | 69.93% |
| Earnings Per Share | -- | $-0.03 | $-0.02 | $-0.59 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.09M | -$540.15K | -$476.86K | -$476.93K |
| Effective Tax Rate | -1.53% | -3.04% | -0.35% | -0.38% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.